Benign fasciculation syndrome and migraine aura without headache as possible adverse events after BNT162b2 mRNA vaccination: a web-based survey [PDF]
, 2023 Grgur Salai +3 more
openalex +1 more source
Author Correction: Differential neutralizing antibody responses elicited by CoronaVac and BNT162b2 against SARS-CoV-2 Lambda in Chile [PDF]
, 2022 Mónica L. Acevedo +15 more
openalex +1 more source
Guillain–Barré syndrome after BNT162b2 (Pfizer-BioNTec) vaccination
QJM: An International Journal of Medicine, 2022 K Takahashi +5 more
openaire +2 more sources
Risk of carditis after three doses of vaccination with mRNA (BNT162b2) or inactivated (CoronaVac) covid-19 vaccination: a self-controlled cases series and a case–control study [PDF]
, 2023 Min Fan +10 more
openalex +1 more source
Comparison of humoral and cellular immune responses in hematologic diseases following completed vaccination protocol with BBIBP-CorV, or AZD1222, or BNT162b2 vaccines against SARS-CoV-2 [PDF]
, 2023 Enikő Szabó +12 more
openalex +1 more source
Effectiveness of BNT162b2 against COVID-19 in adolescents
The Lancet Infectious Diseases, 2022 Powell, Annabel A +8 more
openaire +2 more sources
Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination
Infectious Diseases and TherapyIntroduction Rare myocarditis and pericarditis cases have occurred in coronavirus disease 2019 (COVID-19) messenger RNA (mRNA) vaccine recipients. Troponin levels, a potential marker of myocardial injury, were assessed in healthy participants before and ...
Timothy E. Albertson +25 more
doaj +1 more source
COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study [PDF]
, 2021 Utkarsh Agrawal +30 more
openalex +1 more source
BNT162b2 Vaccine Booster and Covid-19 Mortality
New England Journal of Medicine, 2022 openaire +3 more sources